Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The German ADPKD Tolvaptan Treatment Registry is a Prospective, Observational, Multicentric Study of Patients Suffering From ADPKD That Are Considered for Tolvaptan Treatment.

NCT02497521 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT02497521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02497521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The German ADPKD Tolvaptan Treatment Registry is a Prospective, Observational, Multicentric Study of Patients Suffering From ADPKD That Are Considered for Tolvaptan Treatment.
Lead sponsor
University of Cologne
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2015
Completion date
December 31, 2027
Enrollment
2,000 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

adpkd (autosomal dominant polycystic kidney disease)